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Edited by Mark StittAbstract Cannabidiolic-acid (CBDA) synthase is the enzyme
that catalyzes oxidative cyclization of cannabigerolic-acid into
CBDA, the dominant cannabinoid constituent of the ﬁber-type
Cannabis sativa. We cloned a novel cDNA encoding CBDA syn-
thase by reverse transcription and polymerase chain reactions
with degenerate and gene-speciﬁc primers. Biochemical charac-
terization of the recombinant enzyme demonstrated that CBDA
synthase is a covalently ﬂavinylated oxidase. The structural and
functional properties of CBDA synthase are quite similar to
those of tetrahydrocannabinolic-acid (THCA) synthase, which
is responsible for the biosynthesis of THCA, the major cannab-
inoid in drug-type Cannabis plants.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Cannabinoids, which are found only in Cannabis sativa, are
secondary metabolites possessing alkylresorcinol and monoter-
pene moieties in their molecules. More than 60 cannabinoids
have been isolated from marijuana or fresh Cannabis leaves
[1]. Among them, tetrahydrocannabinol (THC) is the well-
known psychoactive component of marijuana [2]. Recent stud-
ies have demonstrated that this cannabinoid exerts a variety of
therapeutic activities through the cannabinoid receptors CB1
and CB2, which exist in the mammalian brain and immune
cells, respectively [3,4]. Besides THC, the pharmacological
properties of cannabidiol (CBD), an isomer of THC, have also
attracted a great deal of attention although this cannabinoid
does not activate cannabinoid receptors. For example, it has
been reported that CBD is a potent antioxidative and anti-
inﬂammatory agent providing neuroprotection against acuteAbbreviations: CBD, cannabidiol; CBDA, cannabidiolic-acid;
CBDAS, cannabidiolic-acid synthase cDNA; CBGA, cannabigerolic-
acid; THC, tetrahydrocannabinol; THCA, tetrahydrocannabinolic-
acid
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doi:10.1016/j.febslet.2007.05.043and chronic neurodegeneration [5,6]. Thus, cannabinoids such
as THC and CBD are regarded as promising medicinal re-
sources for treating various diseases [7].
Cannabinoids are classiﬁed into two types, neutral cannabi-
noids and cannabinoid acids, based on whether they contain
a carboxyl group or not. It is known that, in fresh plants, the
concentrations of neutral cannabinoids are much lower than
those of cannabinoid acids. Thus, THC and CBD are derived
artiﬁcially from their acidic precursors tetrahydrocannabin-
olic-acid (THCA) and cannabidiolic acid (CBDA) by non-
enzymatic decarboxylation [8,9] (Fig. 1). With respect to the
biosynthesis of cannabinoids, we have previously reported the
identiﬁcation and puriﬁcation of novel enzymes, THCA syn-
thase and CBDA synthase, which are speciﬁcally expressed in
respective drug-type (THCA-rich) and ﬁber-type (CBDA-rich)
chemical phenotypes of C. sativa [10,11]. These enzymes are the
ﬁrst cannabinoid synthases to be studied, and potentially
attractive targets for various biotechnological applications as
they produce the direct precursors of pharmacologically active
cannabinoids. In addition, these enzymes catalyze an unique
biosynthetic reaction, the stereospeciﬁc oxidative cyclization
of the geranyl group of cannabigerolic-acid (CBGA) (Fig. 1),
for which no equivalent reaction has been reported to date.
Furthermore, the structural, functional, and genetic relation-
ship between THCA synthase and CBDA synthase is also of
great interest.
The interesting properties of cannabinoid synthases led us to
attempt the molecular cloning of these enzymes, and recently,
we have successfully obtained a cDNA encoding THCA syn-
thase from a drug-type Cannabis plant (Mexican strain) [12].
The biochemical characterization of the recombinant enzyme
demonstrated that THCA synthase is a covalently ﬂavinylated
oxidase [12]. In addition, we have developed THCA-producing
tobacco hairy roots by using recombinant techniques, opening
the way to the biotechnological production of THCA [12]. In
contrast to THCA synthase, CBDA synthase has remained to
be further studied at the molecular level. In the present study,
we cloned and characterized a novel cDNA (CBDAS) encoding
CBDA synthase from a ﬁber-type C. sativa (CBDA strain).2. Materials and methods
2.1. Plant materials and reagents
C. sativa plants (CBDA strain) [13] were cultivated in the herbal
garden of the Graduate School of Pharmaceutical Sciences, Kyushu
University. CBDA was puriﬁed from dried leaves of C. sativa [14],
and CBGA was chemically synthesized as described previously [11].blished by Elsevier B.V. All rights reserved.
Fig. 1. Biogenesis of THC and CBD. THCA synthase and CBDA
synthase catalyze oxidative cyclization of the monoterpene moiety of
CBGA to form THCA and CBDA, respectively. Then, THC and CBD
are generated from THCA and CBDA by non-enzymatic decarbox-
ylation.
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Takara (Tokyo, Japan) and Toyobo (Osaka, Japan). Biochemical
reagents were purchased from Sigma and Wako (Osaka, Japan).
2.2. Microsequencing of CBDA synthase
CBDA synthase was puriﬁed from rapidly expanding leaves of
C. sativa [11]. The N-terminal amino acid sequence was analyzed on
an Applied Biosystems 473A protein sequencer. Internal sequences
were determined by the sequencing of peptide fragments of CBDA syn-
thase prepared with endoproteinase Glu-C.
2.3. RNA extraction and reverse transcription
Total RNA was extracted from rapidly developing leaves of C. sati-
va by the acid–guanidinium–phenol–chloroform method [15]. The ﬁrst
strand cDNA was synthesized by using reverse transcriptase and an
oligo(dT) primer (primer i below). Poly(dA)-tailed cDNA was pre-
pared with terminal deoxynucleotidyl transferase.
2.4. Cloning and sequencing of CBDAS
The following oligonucleotide primers were used: degenerate primers
a (5 0-GGGGTACCAAYCCIMGIGARAAYTTYYTIAA-3 0) and b
(5 0-CGGGATCCGCICKRTGNGGRAAIGGDATIGC-3 0) designed
from peptide sequences of CBDA synthase, NPRENFLK and AIPF-
PHRA, respectively; gene-speciﬁc primers c (5 0-TAGATCCGCTGG-
GCAGAACG-3 0), d (5 0-GGGGTACCTAGGAGCTGGGATGTAT-
GCG-3 0), e (5 0-AGACATGTGAAGGAGTGACG-3 0), f (5 0-GGGG-
TACCGGGTTGTGTCAGAGGTGAATC-3 0), g (5 0-GGGGATC-
CATGAAGTGCTCAACATTCTC-30) and h (5 0-CTAGCTGAGCT-
CTTAATGACGATGCCGTGG-3 0); and adapter primers i (5 0-GAC-
TCGTCTAGAGGATCCCG-(T)17-3
0) and j (5 0-GACTCGTCTAGA-
GGATCCCG-3 0).
All cDNA fragments were ampliﬁed by PCR using Taq DNA poly-
merase. First, the core fragment (1200 bp) was obtained by PCR with
degenerate primers a and b. The 3 0-terminal region was ampliﬁed by
rapid ampliﬁcation of cDNA ends (3 0-RACE) [16] as follows. The ﬁrst
round of PCR was conducted with gene-speciﬁc primer c and adapter
primer j, and the nested PCR with gene-speciﬁc primer d and adapter
primer j yielded a 600-bp fragment. The 5 0-upstream region of
the cDNA (350 bp) was also ampliﬁed using a similar strategy(5 0-RACE) [16]. The ﬁrst round of PCR was performed with gene-spe-
ciﬁc primer e and adapter primer i in the presence of poly(dA)-tailed
cDNA. The cDNA fragment was obtained by nested PCR with
gene-speciﬁc primer f and adapter primer j. All PCR products were
cloned into the vector pUC119 and sequenced on an Applied Biosys-
tems 310 genetic analyzer.2.5. Expression of CBDA synthase in insect cell culture
Full-length CBDAS was ampliﬁed using gene-speciﬁc primers g and
h with a proofreading polymerase (KOD DNA polymerase, Toyobo).
The ampliﬁed cDNA was ligated into the vector pFastBac1 (Invitro-
gen), and a recombinant baculovirus harboring CBDAS was prepared
and ampliﬁed according to the manufacturer’s instructions (Invitro-
gen).
For production and puriﬁcation of the recombinant CBDA syn-
thase, a 1000-ml suspension culture of Spodoptera frugiperda cells
(2.0 · 106 cells/ml) was infected with virus at a multiplicity of infec-
tion of 1.0. The culture was harvested 72 h after infection, and centri-
fuged. The supernatant was directly applied to a hydroxylapatite
column (1.0 · 10.0 cm) equilibrated with 10 mM phosphate buﬀer
(pH 7.0) containing 3 mM mercaptoethanol (buﬀer A). The bound
proteins were eluted with a 600-ml linear gradient of buﬀer A to
0.5 M potassium phosphate buﬀer (pH 7.0) containing 3 mM mercap-
toethanol. Fractions containing CBDA synthase activity were applied
to another hydroxylapatite column (1.0 · 10.0 cm). The recombinant
CBDA synthase was eluted with a 600-ml gradient of NaCl (0–2 M)
in buﬀer A. The most active fractions were used for the biochemical
characterization.2.6. Spectroscopic characterization of CBDA synthase and its peptide
fragment
The absorption spectrum of the recombinant CBDA synthase was
measured on a Hitachi Model U-2001 spectrophotometer. For ﬂuores-
cence analysis, the recombinant enzyme dissolved in 100 mM sodium
citrate buﬀer (pH 4.0) was irradiated at 450 nm, and the ﬂuorescence
emission spectrum was measured on a Hitachi Model F-2000 ﬂuorom-
eter. Flavin peptide was prepared and characterized as follows. 100 lg
of CBDA synthase was digested with trypsin and chymotrypsin, and
the resulting ﬂavin peptide solution was treated with phosphodiester-
ase. Fluorescence emission spectra of peptide samples before and after
phosphodiesterase treatment were analyzed as described above. The re-
lease of AMP from ﬂavin peptide was detected enzymatically by using
adenylate kinase [17].2.7. Construction of H114A mutant
The mutant cDNA was prepared by a PCR-based mutagenesis [18].
The oligonucleotide primer used was 5 0-AAGCGGTGGCGCTGAT-
GCTGAG-30 in the sense direction (New Ala codon in boldface).
The prepared mutant cDNA was introduced into pFastbac1, and
the H114A enzyme was expressed by the baculovirus expression system.2.8. CBDA synthase Assay
The standard reaction mixture consisted of 200 lMCBGA, 0.1% (w/
v) Triton X-100, and 100 mM sodium citrate buﬀer (pH 5.0) in a total
volume of 500 ll. The reaction was started by adding 100 ll of enzyme
solution, and the mixture was incubated at 30 C for 24 h. After termi-
nation of the reaction with 600 ll of methanol, a 100-ll aliquot was
subjected to analytical HPLC [11].
To examine the molecular oxygen requirement of CBDA synthase,
the substrate and enzyme solutions were pre-incubated with glucose
oxidase and catalase in the presence of glucose [19]. The hydrogen per-
oxide generated after the CBDA synthase reaction was quantiﬁed using
a horseradish peroxidase with 4-aminoantipyrine as substrate [20].3. Results and discussion
3.1. cDNA cloning and structural characteristics of CBDA
synthase
The cloning of CBDAS was carried out by reverse transcrip-
tion and polymerase chain reactions. To design degenerate
Table 1





The letter X indicates that the identity of the amino acid is ambiguous.
F. Taura et al. / FEBS Letters 581 (2007) 2929–2934 2931PCR primers, we analyzed partial amino acid sequences of
CBDA synthase puriﬁed from C. sativa. First, we determined
the N-terminal sequence of the enzyme containing 25 amino
acid residues (Table 1). The puriﬁed enzyme was then treatedFig. 2. Nucleotide and deduced amino acid sequences of CBDA synthase. Th
underlined. The putative signal peptide cleavage site is indicated by an arrow
ﬂavin-binding site consensus sequence is boxed.with endoproteinase Glu-C, and the resulting fragments
(Glu-C-1 and Glu-C-2) were N-terminally sequenced (Table 1).
When PCR was carried out using the degenerate primers de-
signed from the N-terminal and Glu-C-1 sequences, a 1200-
bp PCR product was obtained. The ampliﬁcation of cDNA
fragments containing 3 0- and 5 0-end regions was achieved by
3 0- and 5 0-RACE, respectively. Then, PCR with gene-speciﬁc
primers successfully ampliﬁed the full-length cDNA named
CBDAS (GenBank Accession No. AB292682). CBDAS is
the second gene involved in cannabinoid biosynthesis to be
cloned.
This gene consisted of a 1632-nucleotide open reading frame
encoding a 544-amino acid polypeptide (Fig. 2). The deducede amino acid sequences determined from the puriﬁed native enzyme are
. The asterisks indicate potential Asn-glycosylation sites. The putative
2932 F. Taura et al. / FEBS Letters 581 (2007) 2929–2934primary structure contained all the partial amino acid se-
quences. PSORT analysis (http://psort.nibb.ac.jp/) of the se-
quence indicated that the ﬁrst 28 amino acid residues
constitute a cleavable signal peptide (Fig. 2), being consistent
with the N-terminal start position of CBDA synthase. Hence,
we concluded that mature CBDA synthase consists of 517 ami-
no acid residues. However, the theoretical molecular weight
(58,863 Da) calculated from the amino acid composition of
the mature protein is apparently lower than that (74 kDa)
of the enzyme puriﬁed from C. sativa [11]. The diﬀerence
may be due to post-translational modiﬁcations such as glyco-
sylation, since 7 possible Asn-glycosylation sites were con-
ﬁrmed to be present in mature CBDA synthase (Fig. 2).
It is of great interest to reveal the structural homology be-
tween CBDA synthase and THCA synthase as these enzymes
catalyze similar oxidocyclization reactions with the common
substrate CBGA. Hence, we aligned the amino acid sequences
of these cannabinoid synthases, and found that the primary
structure of CBDA synthase has a surprising level of homol-
ogy to that of THCA synthase (83.9% identity in a 544-amino
acid overlap). The high sequence identity clearly indicated the
evolutional relationship between these cannabinoid synthases,
and suggested that CBDA synthase and THCA synthase devel-
oped from a common ancestor via changes in the amino acid
residues governing the structure of their products.
CBDAsynthase also showed considerable homology (40–50%
identity) to several oxidoreductases such as berberine bridge en-
zyme in Eschscholzia californica, which is involved in alkaloid
biosynthesis, and nectarinV inNicotiana langsdorﬃi · N. sande-
rae, which acts as a glucose oxidase [21,22]. These plant enzymes
as well as THCA synthase are ﬂavoenzymes having a covalently
attached FAD molecule. Furthermore, motif analysis (http://
myhits.isb-sib.ch/cgi-bin/motif_scan/) suggested that CBDA
synthase is also a ﬂavinylated enzyme; the sequence (Arg-Ser-
Gly-Gly-His), which is characteristic of FAD-binding sites in
the above ﬂavoenzymes [12,21,22], was conﬁrmed inCBDAsyn-
thase (Fig. 2). It is interesting to note that ﬂavoenzymes having
apparently diﬀerent catalytic functions show high sequence
homology to each other.Fig. 3. Analyses of ﬂavin attachment to the recombinant CBDA synthase. (
Lane 1, molecular mass standards; lanes 2 and 3, 5 lg of the enzyme. Protei
transillumination at 366 nm (lane 3). (B) The absorption spectrum of the enz
containing 3 mM mercaptoethanol. (C) The ﬂuorescence emission spectrum
4.0). The sample was irradiated at 450 nm.3.2. Heterologous expression of CBDA synthase in insect cell
cultures
We attempted the heterologous expression of CBDA syn-
thase using a baculovirus–insect cell expression system. The
enzyme expression was induced by infecting the insect cells
with a baculovirus harboring CBDAS. After 3 days of incuba-
tion, the CBDA synthase activity in the cell extract and in the
culture medium was measured. As a result, activity was ob-
served only in the culture medium, indicating that most of
the enzyme was secreted from insect cells. The recombinant
CBDA synthase in the insect culture medium was readily puri-
ﬁed to a homogeneous protein with a molecular mass of
62 kDa by hydroxylapatite column chromatography
(Fig. 3A). The N-terminal amino acid sequence of the recom-
binant enzyme was identical to that of the native enzyme, sug-
gesting that the signal peptide was correctly cleaved in insect
cells to sort the mature polypeptide into the secretory pathway.
These results implied that CBDA synthase is a secreted biosyn-
thetic enzyme as in the case of THCA synthase that operates in
the apoplastic space of the glandular trichome of C. sativa [23].
Because the recombinant enzyme was catalytically active, it
is evident that CBDAS encodes an active CBDA synthase.
However, it was quite diﬃcult to perform the kinetic evalua-
tion of the reaction because the recombinant enzyme showed
much less activity than the native CBDA synthase, and pro-
longed incubation was required to detect the synthesized
CBDA in a HPLC analysis. The weak catalytic activity of
the recombinant enzyme raised the possibility that another
gene encoding more active enzyme has not been found. Thus,
we made further eﬀorts to clone another candidate gene by
using various PCR conditions. However, we could not amplify
gene fragments other than CBDAS from the cDNA solution.
On the other hand, two gene fragments, both of which contain
a 1635-bp intronless open reading frame, were obtained when
PCRs were performed with genomic DNA as the template.
The genes, named CBDAS2 and CBDAS3 (GenBank Acces-
sion Nos. AB292683 and AB292684), encoded 545-amino acid
proteins that share 84.6% and 84.0% identity with the primary
structure deduced from CBDAS, respectively. In spite of theA) SDS–PAGE analysis of the puriﬁed recombinant CBDA synthase.
n bands were visualized by Coomassie blue staining (lanes 1 and 2) or
yme (4.2 mg/ml) dissolved in 10 mM sodium phosphate buﬀer (pH 7.0)
of the enzyme (1 mg/ml) dissolved in 10 mM sodium citrate buﬀer (pH
F. Taura et al. / FEBS Letters 581 (2007) 2929–2934 2933structural similarity, the partial amino acid sequences of native
CBDA synthase were not completely conserved in CBDAS2
and CBDAS3, and further, the recombinant enzymes prepared
from these clones did not exhibit CBDA synthase activity
(Data not shown). From these results, we concluded that
CBDAS is the dominantly expressed cDNA for CBDA syn-
thase, and the weak activity of the recombinant enzyme might
be due to incorrect folding resulting from the diﬀerences
between the insect and plant protein biosynthetic machinery.
Further studies are now in progress to prepare a recombinant
CBDA synthase with catalytic activity comparable to that of
the native enzyme. The eﬀective expression of the enzyme will
be helpful in developing a biotechnological production system
for CBDA, as we previously reported on artiﬁcial THCA pro-
duction in transgenic tobacco expressing THCA synthase [12].
3.3. Coenzyme binding and reaction mechanism of CBDA
synthase
The reaction mechanism of CBDA synthase has been un-
clear because this enzyme requires neither coenzymes nor
cofactors for the oxidation of CBGA [11]. However, in the
present study, the sequence analysis indicated the possibility
that CBDA synthase possesses a ﬂavin that acts as a coenzyme.
We thus next attempted to identify the coenzyme that binds to
this enzyme by conducting various spectroscopic analyses of
the recombinant enzyme.
The concentrated solution of the puriﬁed recombinant
CBDA synthase gave a yellow coloration and transillumina-
tion of the enzyme at 366 nm showed autoﬂuorescence on
SDS–PAGE (Fig. 3A). In addition, the enzyme solution
showed absorbance maxima at 365 nm and 450 nm (Fig. 3B),
and a ﬂuorescence emission maximum at 515 nm (Fig. 3C).
Further, trichloroacetic-acid treatment did not release the
compound exhibiting autoﬂuorescence from the enzyme. These
properties were consistent with those of ﬂavoproteins [24,25],
indicating that CBDA synthase has a covalently bound ﬂavin.
The majority of covalently ﬂavinylated enzymes contain
FAD, but several enzymes possessing FMN have been identi-Fig. 4. The reaction mechanisms of CBDA synthase and THCA synthase. T
and then transferred to molecular oxygen to re-oxidize FAD. CBDA and T
cyclization by the enzymes. R, the rest of the FAD molecule. B, the proposﬁed [26]. We next attempted to identify the ﬂavin that attaches
to CBDA synthase as follows. A ﬂavin-bound peptide was pre-
pared by partial hydrolysis of the recombinant enzyme with
trypsin and chymotrypsin. Phosphodiesterase treatment of this
peptide resulted in a 1.5-fold increase of ﬂuorescence emis-
sion at 515 nm, along with the release of AMP, suggesting that
FMN was formed by cleavage of the phosphodiester bond in
FAD [25]. These results showed that FAD binds to the en-
zyme. Based on a comparison of the molar extinction coeﬃ-
cient of the enzyme at 450 nm with that of authentic FAD,
the molar ratio of FAD to CBDA synthase was concluded
to be 1:1. We also conﬁrmed that, as reported for THCA syn-
thase, the FAD-binding site of CBDA synthase is His-114 in
the ﬂavinylation consensus sequence (Arg-Ser-Gly-Gly-His)
because a mutant with a site-directed mutation at this position
(H114A) did not show spectroscopic characteristics. In addi-
tion, the H114A mutant enzyme exhibited no CBDA synthase
activity, indicating that the CBDA synthase reaction is depen-
dent on FAD.
We previously reported that THCA synthase requires molec-
ular oxygen to oxidize CBGA and produces hydrogen perox-
ide as well as THCA demonstrating that THCA synthase is
an oxidase like structurally related enzymes such as berberine
bridge enzyme [12]. The structural similarity between CBDA
synthase and THCA synthase suggests that the CBDA syn-
thase reaction proceeds through a mechanism similar to that
of the THCA synthase reaction. Therefore, we evaluated the
eﬀect of molecular oxygen on the CBDA synthase reaction
using a glucose–glucose oxidase–catalase system, which com-
pletely consumes the molecular oxygen in assay solutions
[19]. Consequently, the CBDA synthase reaction was com-
pletely inhibited by this treatment, conﬁrming that the reaction
absolutely depends on molecular oxygen. In addition, the en-
zyme reaction produced hydrogen peroxide proportional to
CBDA.
Based on these biochemical properties of the enzyme, we pro-
pose here the reaction mechanism of CBDA synthase (Fig. 4),
which is similar to the previously reported mechanism forwo electrons from the substrate are accepted by enzyme-bound FAD,
HCA are synthesized from the ionic intermediates via stereoselective
ed basic residue of the enzyme.
2934 F. Taura et al. / FEBS Letters 581 (2007) 2929–2934THCA synthase [12] (Fig. 4). The reactions of both enzymes are
initiated by the transfer of a hydride ion from the diallylic posi-
tion of CBGA to the reactive N-5 position of the isoalloxazine
ring of FAD [27]. The important diﬀerence between the two
reactions is seen in the proton transfer step; i.e. CBDA synthase
abstracts a proton from the terminal methyl group of CBGA,
whereas a proton is removed from a hydroxyl group of the sub-
strate in the THCA synthase reaction. After the protons elimi-
nation, the ﬁnal step of the reaction, stereoselective ring closure
to form CBDA and THCA, takes place in the active sites of
each cannabinoid synthase. On the other hand, the hydride
ion is transferred from the reduced ﬂavin to molecular oxygen,
resulting in the formation of hydrogen peroxide and re-activa-
tion of the ﬂavin for the next cycle. Because of these functional
similarities, only a small number of amino acid residues would
determine the product speciﬁcity of the two cannabinoid syn-
thases. Recently, we started the X-ray crystallographic analysis
of cannabinoid synthases to unequivocally determine the reac-
tion mechanisms, including the amino acid residues regulating
the product speciﬁcity, at the atomic level. We have already ob-
tained crystals of the recombinant THCA synthase by a hang-
ing drop vapor diﬀusion method, and reported their
preliminary characterization [28]. Subsequent studies should
demonstrate the structure–function relationship of the enzyme
active sites, and may provide a rational strategy for controlling
the oxidocyclization reaction to eﬀectively produce natural and
unnatural cannabinoids.
In conclusion, we have characterized a novel cDNA encoding
CBDA synthase, and provided evidence for a close relationship
between CBDA synthase and THCA synthase, suggesting that
CBDA and THCA, the chemotype-determining cannabinoids,
are biosynthesized with similar reaction mechanisms in ﬁber-
type and drug-type Cannabis plants, respectively.Acknowledgments: We thank Dr. Yuji Ito for determining amino acid
sequences. This research was partially supported by Grants-in-Aid
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